Omeros Corporation
OMER
#6314
Rank
S$1.06 B
Marketcap
S$14.98
Share price
1.32%
Change (1 day)
-1.83%
Change (1 year)

Omeros Corporation (OMER) - Cash on Hand

Cash on Hand as of June 2025 : S$37.28 Million

According to Omeros Corporation's latest financial reports the company has S$37.28 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Omeros Corporation - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.12 B-46.02%
2023-12-31S$0.22 B-13.14%
2022-12-31S$0.26 B22.9%
2021-12-31S$0.21 B19.09%
2020-12-31S$0.17 B117.85%
2019-12-31S$81.95 M-0.84%
2018-12-31S$82.64 M-26.22%
2017-12-31S$0.11 B70.73%
2016-12-31S$65.6 M64.11%
2015-12-31S$39.97 M339.39%
2014-12-31S$9.09 M-49.07%
2013-12-31S$17.86 M-34.63%
2012-12-31S$27.33 M-14.1%
2011-12-31S$31.81 M-41.18%
2010-12-31S$54.09 M-36.11%
2009-12-31S$84.66 M196.27%
2008-12-31S$28.57 M-17.54%
2007-12-31S$34.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
S$3.95 M-89.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
S$0.88 M-97.62%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
S$19.43 B 52,029.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$24.08 B 64,476.96%๐Ÿ‡บ๐Ÿ‡ธ USA